Assessment of a Decision Support System for Adults with Type 1 Diabetes on Multiple Daily Insulin Injections
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.The DailyDose system did not significantly improve glycemic outcomes for type 1 diabetes patients. However, accepting its insulin dosing recommendations correlated with increased time in range.
Area Of Science
- Endocrinology
- Medical Informatics
- Diabetes Technology
Background
- Type 1 diabetes management requires precise insulin dosing.
- Multiple daily insulin injections (MDI) are a common treatment regimen.
- Decision support systems aim to aid diabetes self-management.
Purpose Of The Study
- To evaluate the efficacy of the DailyDose decision support system.
- To assess its impact on glycemic control in adults with type 1 diabetes on MDI.
- To determine if system usage improves time in range (TIR).
Main Methods
- Single-arm study involving 25 adults with type 1 diabetes.
- Participants used the DailyDose system on an iPhone for 8 weeks.
- Continuous glucose monitoring (Dexcom G6) and insulin pen data (InPen, Clipsulin) were utilized.
Main Results
- No significant difference in TIR or glycemic metrics between baseline and DailyDose use.
- A significant TIR improvement of 6.3% was observed when >50% of DailyDose recommendations were followed.
- Post hoc analysis indicated adherence to recommendations improved TIR.
Conclusions
- DailyDose system use alone did not demonstrate significant glycemic improvements.
- Adherence to system recommendations is crucial for potential benefits in TIR.
- Further research may explore optimizing user engagement with such systems.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
Related Concept Videos
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...